Abolfazl Olyaei | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Forensic Scientist Awards

Best Researcher Award

Abolfazl Olyaei
Imam Khomeini International University Faculty of Science, Iran
Abolfazl Olyaei
Affiliation Imam Khomeini International University Faculty of Science
Country Iran
Scopus ID 14009290900
Documents 94
Citations 1,047
h-index 18
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Forensic Scientist Awards
ORCID 0000-0003-2976-9481

The Best Researcher Award recognizes sustained scholarly achievement and measurable scientific impact within a specialized discipline. This article summarizes the academic profile of Abolfazl Olyaei, whose research activities focus on heterocyclic chemistry, green synthetic methodologies, medicinal chemistry, and pharmaceutical sciences. The information presented is based on publicly available scholarly records, publication metadata, citation indicators, and institutional affiliations.[1]

Abstract

Abolfazl Olyaei has established a consistent research portfolio in synthetic organic chemistry with emphasis on environmentally friendly reaction pathways, heterocyclic compounds, and biologically active molecular frameworks. His publication record demonstrates continuing contributions toward sustainable synthetic methodologies and pharmaceutical chemistry, supported by strong citation performance and international journal publications.[2]

Keywords

Green Chemistry, Heterocyclic Synthesis, Pharmaceutical Science, Organic Chemistry, Medicinal Chemistry, Catalysis, Sustainable Synthesis, Toxicology.

Introduction

Modern pharmaceutical research increasingly emphasizes sustainable chemical synthesis and efficient production of biologically relevant compounds. Dr. Olyaei’s investigations contribute to these objectives by exploring one-pot multicomponent reactions, environmentally benign solvents, and innovative heterocyclic scaffolds applicable to medicinal chemistry.[3]

Research Profile

According to indexed scholarly databases, the researcher has produced 94 publications with more than one thousand citations and an h-index of 18. His academic work spans pharmacology, toxicology, pharmaceutical science, and advanced organic synthesis. Collaborative publications appear in internationally recognized journals including RSC Advances and ChemistrySelect.[1]

Research Contributions

  • Development of green multicomponent synthetic methodologies.
  • Investigation of heterocyclic compounds with pharmaceutical relevance.
  • Promotion of aqueous and environmentally friendly reaction media.
  • Review articles summarizing biologically active molecular frameworks.

Publications

  • Aqueous glyoxal: a versatile synthon in heterocyclic synthesis. RSC Advances (2026).
  • Regioselective green synthesis of indole-substituted benzo[f]chromenes. RSC Advances (2026).
  • Sequential Tandem Four-Component Reaction. ChemistrySelect (2025).
  • Review on synthesis of furonaphthoquinones. RSC Advances (2025).
  • Acid-Mediated One-Pot Three-Component Tandem Cyclization. ChemistrySelect (2024).

Research Impact

The citation profile and publication output indicate sustained scholarly influence in synthetic and medicinal chemistry. Research themes emphasize reproducibility, environmentally responsible synthesis, and development of biologically relevant compounds, reflecting continued engagement with internationally recognized scientific challenges.[4]

Award Suitability

Based on documented publication productivity, citation performance, peer-reviewed contributions, and relevance to pharmaceutical and forensic sciences, the academic profile demonstrates characteristics commonly considered during international research award evaluations. This assessment reflects publicly available scholarly evidence rather than endorsement.[5]

Conclusion

Abolfazl Olyaei has developed a noteworthy academic record through sustained publication, interdisciplinary collaboration, and contributions to green synthetic chemistry. His research continues to support advances in pharmaceutical science and heterocyclic chemistry while maintaining international scholarly visibility through indexed publications and measurable citation impact.

External Links

References

  1. Elsevier. Scopus Author Details: Abolfazl Olyaei, Author ID 14009290900.
    https://www.scopus.com/authid/detail.uri?authorId=14009290900
  2. ORCID. Researcher Profile.
    https://orcid.org/0000-0003-2976-9481
  3. RSC Advances. Aqueous glyoxal: a versatile synthon in heterocyclic synthesis.
    https://doi.org/10.1039/D5RA08496B
  4. ChemistrySelect. Sequential Tandem Four-Component Reaction.
    https://doi.org/10.1002/slct.202505685
  5. International Forensic Scientist Awards. Official Award Website.
    forensicscientist.org

Leng Chee Chang | Pharmacology | Research Excellence Award

Published on by Forensic Scientist Awards

Prof. Dr. Leng Chee Chang | Pharmacology | Research Excellence Award

University of Hawaii at Hilo | United States

Prof. Dr. Leng Chee Chang is a natural products chemist whose work focuses on the isolation, characterization, and biological evaluation of bioactive compounds from medicinal plants, marine algae, and microbes with applications in cancer chemoprevention, chemotherapeutics, and antimicrobial discovery. According to Scopus-indexed records, she has authored 73 publications, which have been cited 2,567 times, reflecting a substantial global research impact. Her h-index of 28 highlights consistent scholarly influence and sustained citation performance across her body of work. Dr. Chang’s research has appeared in high-impact journals such as Organic Letters, Journal of Natural Products, Molecules, and ACS Omega, and encompasses multidisciplinary collaborations in pharmacognosy, medicinal chemistry, and pharmacology. Her work has contributed to the discovery of novel natural products with therapeutic potential.

                            Citation Metrics (Scopus)

3000

2500

2000

1500

1000

500

0

 

Citations
2567
Documents
73
h-index
28

Citations

Documents

h-index

View Scopus Profile

Featured Publications


A New Trichlorinated Xanthone and Compounds Isolated from Cladonia skottsbergii with Antimicrobial Properties

– Rositzki MJ, Raksat A, Simmons CJ, Smith C, Reverend Danette V. Choi, Wongwiwatthananukit S, Chang LC · Pharmaceuticals, 2026


Bioactive Constituents from the Edible Seaweed Halymenia hawaiiana (Rhodophyta)

– Raksat A, Atanu MSH, McDermimid KJ, Wall MW, Chang BL, Wongwiwatthananukit S, Chang LC · Pharmaceutical Biology, 2025


Bioactive Compounds from Dodonaea viscosa Flowers: Potent Antibacterial and Antiproliferative Effects in Breast Cancer Cells

– Raksat A, Yee D, Gi YJ, Wongwiwatthananukit S, Chang LK, Kaawaloa P, Wall MW, Chang LC · Molecules, 2025 (IF 4.2)


Biologically Active Withanolides from Physalis peruviana L.

– Sang-Ngern M, Fukuchi A, Kondratyuk TP, Park E-J, Simmons CJ, Wall MW, Lorch SE, Pezzuto JM, Chang LC · Pharmaceutical Biology, 2025


Vernonolide A, a Sesquiterpene Lactone with a Unique Carbon Skeleton from Vernonia cinerea

– Zhang M, Kondratyuk TP, Cao S, Li M, Songsak T, Wongwiwatthananukit S, Cai Y-S, Chang LC · Organic Letters, 2025 (IF 4.9)

 

Arman Soltani Moghadam | Medicine | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Arman Soltani Moghadam | Medicine | Best Researcher Award

Tehran Herat Center | Iran

Dr. Arman Soltani Moghadam is a dedicated medical doctor and cardiovascular researcher based in Tehran, Iran. With a strong foundation in clinical medicine and an exceptional academic record, he has significantly contributed to cardiology through both clinical practice and extensive research collaborations internationally. Known for his precision in diagnostics and passion for scientific inquiry, he serves as a General Practitioner while actively engaging in cutting-edge cardiovascular research with institutions such as Tehran University of Medical Sciences and the University of Arizona.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Dr. Arman Soltani Moghadam demonstrates a rare blend of clinical expertise, academic excellence, and prolific research productivity at a remarkably early career stage. With dual appointments in top-tier institutions such as Tehran Heart Center and the University of Arizona, he brings international collaboration into practice. His extensive publication record, including meta-analyses in high-impact journals like Journal of the American Heart Association, Clinical Cardiology, and Frontiers in Immunology, underlines his commitment to evidence-based cardiology. His editorial contributions to BMJ and Artificial Organs, as well as multiple conference abstracts presented at AHA and ACC, show active involvement in shaping the scientific dialogue.

Moreover, his ability to work across disciplines—ranging from echocardiography and interventional cardiology to artificial intelligence in medicine—shows a visionary mindset. His numerous certifications from Oxford, Johns Hopkins, and Coursera on clinical trials, machine learning, and statistical methods further reinforce his scientific rigour. Notably, his early leadership as a corresponding author and multiple first-author meta-analyses reflect originality and independence in research.

🎓 Education

Dr. Moghadam earned his Doctor of Medicine (M.D.) diploma from Islamic Azad University, Tehran Medical Sciences Branch (2014–2021), graduating with a commendable GPA of 3.65/4.0. Prior to that, he completed his Diploma in Natural Science at the National Organization for the Development of Exceptional Talents (NODET), where he achieved a perfect GPA of 4.0/4.0. His strong academic foundation reflects his commitment to lifelong learning and excellence in science.

💼 Experience

Currently, Dr. Moghadam works as a General Practitioner at Amiralam Hospital in Tehran, while concurrently contributing as a Research Assistant in the Department of Cardiology at Tehran University of Medical Sciences. He previously served at Chamran Hospital and completed his internship at Islamic Azad University. Additionally, he collaborates remotely with the University of Arizona as a cardiovascular research assistant, showcasing his global engagement in healthcare research.

🔬 Research Interests On Medicine

Dr. Moghadam’s research is rooted in cardiology, with focused interests in interventional cardiology, structural heart disease, electrophysiology, and echocardiography. His studies aim to bridge clinical observations with evidence-based medicine, frequently employing meta-analytical techniques and advanced statistical tools. He is passionate about improving cardiovascular outcomes through innovation and collaboration.

🏆 Awards and Honors

🏅 Ranked 1st in the Clinical Knowledge Exam among his peers, Dr. Moghadam also secured 2nd position based on GPA in his MD program. He is a recognized member of the Iranian Society of Atherosclerosis (IR SA) and actively participates in national and international scientific communities. His commitment to education is evident from his extensive teaching and mentoring experiences.

📄 Publications

  • Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review
    Authors: AB Boroumand, M Forouhi, F Karimi, AS Moghadam, LG Naeini, …
    Year: 2022
    Cited by: 58

  • Human diseases Research and textbook 1: Heart, Diabetes, Bacterial, ADHD, skin
    Authors: AT Mohammadi, S Karami, A Jahandideh, S Sarejloo, S Vaseghi, …
    Year: 2022
    Cited by: 29

  • The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review
    Authors: A Vakilpour, E Amini-Salehi, A Soltani Moghadam, MH Keivanlou, …
    Year: 2024
    Cited by: 21

  • Emerging Technologies in Medicine: Artificial Intelligence, Robotics, and Medical Automation
    Authors: M Rezaei, S Saei, SJ Khouzani, ME Rostami, M Rahmannia, …
    Year: 2023
    Cited by: 21

  • In Patients with Cardiogenic Shock, Extracorporeal Membrane Oxygenation Is Associated with Very High All-Cause Inpatient Mortality Rate
    Authors: MR Movahed, A Soltani Moghadam, M Hashemzadeh
    Year: 2024
    Cited by: 1

  • Gender-based Disparity in Performing Aortic Valve Surgery in the United State Before Availability of Percutaneous Valve Implantation
    Authors: MR Movahed, AS Moghadam, M Hashemzadeh, M Hashemzadeh
    Year: 2024
    Cited by: 1

  • Revisiting echocardiographic features of prosthetic heart valves: the necessity of correct differentiation of mono-leaflet vs. bileaflet mechanical heart valves in a case report
    Authors: SHAASM Farnoosh Larti’t, Babak Geraiely’t
    Year: 2024
    Cited by: 1

  • Intravascular Lithotripsy Versus Rotational Atherectomy in the Management of Calcific Coronary Lesions: A Systematic Review and Meta‐Analysis
    Authors: AS Moghadam, N Kakavand, FO Shirmard, A Poopak, N Anaraki, …
    Year: 2025
    Cited by: Not available

  • Short‐Term, Mid‐Term, and Long‐Term Outcomes of Transcatheter Aortic Valve Replacement With Balloon‐Expandable Versus Self‐Expanding Valves: A Meta‐Analysis of Randomized Trials
    Authors: K Tavakoli, NSH Mohammadi, P Bahiraie, S Saeidi, F Shaker, …
    Year: 2025
    Cited by: Not available

  • Time Trend Analysis of Clinical Outcomes for Drug-Coated Balloon versus Drug-Eluting Stent among Patients with Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Trials
    Authors: A Soltani Moghadam, S Kazemian, S Shojaei, Saman Soltani Moghadam, …
    Year: 2024
    Cited by: Not available

✅ Conclusion

Dr. Arman Soltani Moghadam exemplifies the fusion of clinical acumen and research innovation. With a diverse portfolio of international collaborations, high-impact publications, and a continuous pursuit of academic and clinical excellence, he stands as a strong nominee for any global medical or research award. His contributions not only enhance cardiovascular knowledge but also inspire the next generation of physician-scientists.

Mohamad Taleuzzaman | Pharmacology | Best Researcher Award

Published on by Forensic Scientist Awards

Prof. Dr. Mohamad Taleuzzaman | Pharmacology | Best Researcher Award

Maulana Azad University | India

Dr. Mohamad Taleuzzaman is a distinguished academician and researcher in the field of pharmaceutical chemistry. With a career spanning over 15 years, he has contributed significantly to pharmaceutical education, research, and administration. Currently serving as a Professor and Head of the Department at Maulana Azad University, Jodhpur, his expertise lies in pharmaceutical analysis, drug development, and bioanalytical research. Passionate about scientific innovation, he has played a vital role in mentoring students and advancing pharmaceutical sciences.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

  • Extensive Research Contributions – Dr. Taleuzzaman has numerous publications in high-impact journals, showcasing his active engagement in research.

  • Diverse Research Interests – His work spans pharmaceutical chemistry, nanotechnology, molecular docking, and bioanalytical method development.

  • Academic Leadership – Serving as a Professor and HOD, he has contributed to institutional development and research coordination.

  • Patent Holder – His patent on a polymeric nano scaffold for anti-diabetic applications highlights his innovation.

  • Mentorship – He has successfully guided Ph.D. and M.Pharm students, contributing to academic growth.

  • Strong Administrative Experience – Coordinating academic inspections, examinations, and regulatory compliance.

Education 🎓

Dr. Taleuzzaman pursued his Ph.D. in Pharmaceutical Chemistry from Glocal University, Saharanpur, in 2018. He completed his M.Pharm in Pharmaceutical Analysis from Jamia Hamdard, New Delhi, securing a first-class distinction with 73.84% in 2007. His academic journey began with a B.Pharm from the same institution in 2005. Additionally, he qualified for the GATE examination in 2005 with an impressive percentile of 92.49, further solidifying his strong foundation in pharmaceutical sciences.

Professional Experience 💼

With over 15 years of professional experience, Dr. Taleuzzaman has held key positions in both academia and the pharmaceutical industry. Since 2019, he has been serving as a Professor and HOD at Maulana Azad University, Jodhpur. Prior to this, he worked as an Associate Professor at Glocal School of Pharmacy, Saharanpur, and as an Assistant Professor at KIET School of Pharmacy, Ghaziabad. His industrial experience includes roles such as Product Development Manager at Ultra Biolabs Pvt. Ltd., Chandigarh, and Quality Officer at Ali & Abdul Karim Trading Co., Oman.

Research Interests On Pharmacology 📚

Dr. Taleuzzaman’s research is centered on pharmaceutical analysis, drug formulation, and bioanalytical method development. His Ph.D. research focused on the extraction, characterization, and quantification of thymoquinone and eugenol from Nigella sativa and Myristica fragrans. He has also explored novel drug delivery systems, nanotechnology applications in pharmaceuticals, and synthetic methodologies for bioactive compounds.

Awards & Recognitions 🏆

Dr. Taleuzzaman has been recognized for his contributions to pharmaceutical sciences and academic excellence. His innovative research has led to a patent titled “Sitagliptin loaded polymeric nano scaffold for enhanced anti-diabetic performance” (Patent number: 2021104076). He has also been actively involved in coordinating major academic accreditations such as PCI, UGC, and NAAC inspections at leading pharmacy institutions.

Publications 📄

Dr. Taleuzzaman has published extensively in high-impact journals. Some of his notable research articles include:

  • Ultra performance liquid chromatography (UPLC)-a review
    Authors: M Taleuzzaman, S Ali, SJ Gilani, SS Imam, A Hafeez
    Year: 2015
    Citations: 133

  • Limit of blank (LOB), limit of detection (LOD), and limit of quantification (LOQ)
    Author: M Taleuzzaman
    Year: 2018
    Citations: 88

  • Eugenol as a potential drug candidate: A review
    Authors: M Taleuzzaman, P Jain, R Verma, Z Iqbal, MA Mirza
    Year: 2021
    Citations: 79

  • Clarithromycin-loaded ocular chitosan nanoparticle: formulation, optimization, characterization, ocular irritation, and antimicrobial activity
    Authors: M Bin-Jumah, SJ Gilani, MA Jahangir, A Zafar, S Alshehri, M Yasir, C Kala, …
    Year: 2020
    Citations: 70

  • Quality by design (Qbd) assisted development of phytosomal gel of aloe vera extract for topical delivery
    Authors: P Jain, M Taleuzzaman, C Kala, D Kumar Gupta, A Ali, M Aslam
    Year: 2021
    Citations: 48

  • Nano phytomedicine based delivery system for CNS disease
    Authors: MA Jahangir, C Anand, A Muheem, SJ Gilani, M Taleuzzaman, A Zafar, …
    Year: 2020
    Citations: 44

  • Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments
    Authors: I Rahat, SS Imam, M Rizwanullah, S Alshehri, M Asif, C Kala, …
    Year: 2021
    Citations: 36

  • Benzothiazole incorporated thiazolidin-4-ones and azetidin-2-ones derivatives: Synthesis and in vitro antimicrobial evaluation
    Authors: SJ Gilani, K Nagarajan, SP Dixit, M Taleuzzaman, SA Khan
    Year: 2016
    Citations: 30

  • Phytosomal gel of Manjistha extract (MJE) formulated and optimized with central composite design of Quality by Design (QbD)
    Authors: M Taleuzzaman, A Sartaj, D Kumar Gupta, SJ Gilani, MA Mirza
    Year: 2023
    Citations: 29

  • Formulation and evaluation of thymoquinone niosomes: Application of developed and validated RP-HPLC method in delivery system
    Authors: SJ Gilani, SS Imam, A Ahmed, S Chauhan, MA Mirza, M Taleuzzaman
    Year: 2019
    Citations: 28

Conclusion 🔗

Dr. Mohamad Taleuzzaman’s dedication to pharmaceutical research and education has made a profound impact on the field. His work in drug development, bioanalytical chemistry, and nanotechnology has contributed to the advancement of pharmaceutical sciences. As a mentor, researcher, and academic leader, he continues to inspire and shape the future of pharmaceutical research.